1-3 of 3
Susan M. Blaney
Close
Sort by
Journal Articles

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma

Clinical Trials & Observations
Elizabeth Fox, Bassem I. Razzouk, Brigitte C. Widemann, Shaun Xiao, Michelle O'Brien, Wendy Goodspeed, Gregory H. Reaman, Susan M. Blaney, Anthony J. Murgo, Frank M. Balis, Peter C. Adamson
Journal: Blood
Blood (2008) 111 (2): 566–573.
https://doi.org/10.1182/blood-2007-08-107839
Published: 2008
Journal Articles

A Phase I Study of Temozolomide (Temodar®) in Pediatric Patients with Relapsed or Refractory Leukemia—A Children’s Oncology Group Study.

Terzah M. Horton, MD, PhD, Eileen Dolan, PhD, Madhuri Hegde, PhD, Stacey L. Berg, MD, Peter Adamson, MD, Susan M. Blaney, MD
Journal: Blood
Blood (2005) 106 (11): 4455.
https://doi.org/10.1182/blood.V106.11.4455.4455
Published: 2005
Journal Articles

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

Clinical Trials & Observations
Martin A. Champagne, Renaud Capdeville, Mark Krailo, Wenchun Qu, Bin Peng, Marianne Rosamilia, Martine Therrien, Ulrike Zoellner, Susan M. Blaney, Mark Bernstein
Journal: Blood
Blood (2004) 104 (9): 2655–2660.
https://doi.org/10.1182/blood-2003-09-3032
Published: 2004